GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relypsa Inc (NAS:RLYP) » Definitions » Piotroski F-Score

Relypsa (Relypsa) Piotroski F-Score : 0 (As of May. 11, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Relypsa Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Relypsa has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Relypsa's Piotroski F-Score or its related term are showing as below:


Relypsa Piotroski F-Score Historical Data

The historical data trend for Relypsa's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relypsa Piotroski F-Score Chart

Relypsa Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Piotroski F-Score
- - - 4.00 4.00

Relypsa Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.00 5.00 4.00 5.00 3.00

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun16) TTM:Last Year (Jun15) TTM:
Net Income was -51.468 + -58.326 + -54.758 + -83.616 = $-248.17 Mil.
Cash Flow from Operations was -9.041 + -53.439 + -80.067 + -79.431 = $-221.98 Mil.
Revenue was 6.59 + 11.96 + 12.382 + 5.221 = $36.15 Mil.
Gross Profit was 6.59 + 11.96 + 12.304 + 4.965 = $35.82 Mil.
Average Total Assets from the begining of this year (Jun15)
to the end of this year (Jun16) was
(320.058 + 315.202 + 278.328 + 261.384 + 321.577) / 5 = $299.3098 Mil.
Total Assets at the begining of this year (Jun15) was $320.06 Mil.
Long-Term Debt & Capital Lease Obligation was $158.58 Mil.
Total Current Assets was $298.47 Mil.
Total Current Liabilities was $42.66 Mil.
Net Income was -19.435 + -27.647 + -29.665 + -39.257 = $-116.00 Mil.

Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Average Total Assets from the begining of last year (Jun14)
to the end of last year (Jun15) was
(171.977 + 155.858 + 151.839 + 343.626 + 320.058) / 5 = $228.6716 Mil.
Total Assets at the begining of last year (Jun14) was $171.98 Mil.
Long-Term Debt & Capital Lease Obligation was $12.89 Mil.
Total Current Assets was $302.22 Mil.
Total Current Liabilities was $31.25 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Relypsa's current Net Income (TTM) was -248.17. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Relypsa's current Cash Flow from Operations (TTM) was -221.98. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun15)
=-248.168/320.058
=-0.77538446

ROA (Last Year)=Net Income/Total Assets (Jun14)
=-116.004/171.977
=-0.67453206

Relypsa's return on assets of this year was -0.77538446. Relypsa's return on assets of last year was -0.67453206. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Relypsa's current Net Income (TTM) was -248.17. Relypsa's current Cash Flow from Operations (TTM) was -221.98. ==> -221.98 > -248.17 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun16)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun15 to Jun16
=158.581/299.3098
=0.52982228

Gearing (Last Year: Jun15)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun14 to Jun15
=12.893/228.6716
=0.05638217

Relypsa's gearing of this year was 0.52982228. Relypsa's gearing of last year was 0.05638217. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun16)=Total Current Assets/Total Current Liabilities
=298.473/42.656
=6.99721024

Current Ratio (Last Year: Jun15)=Total Current Assets/Total Current Liabilities
=302.216/31.254
=9.66967428

Relypsa's current ratio of this year was 6.99721024. Relypsa's current ratio of last year was 9.66967428. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Relypsa's number of shares in issue this year was 44.768. Relypsa's number of shares in issue last year was 41.49. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=35.819/36.153
=0.99076149

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

Relypsa's gross margin of this year was 0.99076149. Relypsa's gross margin of last year was . ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun15)
=36.153/320.058
=0.11295765

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun14)
=0/171.977
=0

Relypsa's asset turnover of this year was 0.11295765. Relypsa's asset turnover of last year was 0. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Relypsa has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Relypsa  (NAS:RLYP) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Relypsa Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Relypsa's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Relypsa (Relypsa) Business Description

Traded in Other Exchanges
N/A
Address
Relypsa Inc is a biopharmaceutical company engaged in the development and commercialization of non-absorbed polymeric drugs to treat disorders in the areas of renal, cardiovascular and metabolic diseases.
Executives
Ronald A. Krasnow officer: See Remarks C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063
Kristine M Ball officer: Chief Financial Officer & SVP C/O RELYPSA, INC., 700 SAGINAW DRIVE, REDWOOD CITY CA 94063
Mcgirr David W J director 33 PHEASANT LANE, GREENWICH CT 06830
Paul J Hastings director 61 HARTFORD STREET, SAN FRANCISCO CA 94114
John A Orwin director, officer: President & CEO C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063
Kenneth J. Hillan director C/O ACHAOGEN, INC., 7000 SHORELINE COURT, SUITE 371, SOUTH SAN FRANCISCO CA 94080
Wilhelm Stahl officer: SVP, Chief Technology Officer C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063
J. Scott Garland officer: SVP & Chief Commercial Officer 210 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
Daniel K Spiegelman director MYRIAD GENETICS, 320 WAKARA WAY, SALT LAKE CITY UT 84003
John P. Butler director C/O RELYPSA, INC., 700 SAGINAW DR., REDWOOD CITY CA 94063
Helen Torley director C/O ONYX PHARMACEUTICALS, INC., 249 EAST GRAND AVE., SOUTH SAN FRANCISCO CA 94080
James D Dondero 10 percent owner 300 CRESCENT COURT, SUITE 700, DALLAS TX 75201
Orbimed Advisors Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Samuel D Isaly 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Orbimed Capital Gp Iv Llc 10 percent owner 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022

Relypsa (Relypsa) Headlines

From GuruFocus

Insiders Buy Stock in Wynn Resorts, Bank of New York Mellon

By Tiziano Frateschi Tiziano Frateschi 10-26-2015